Company intelligence
Life Science Leader
Connect. Collaborate. Contribute.
About Life Science Leader
Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Our content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses. Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharma and biopharma markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes. Life Science Leader is part of Life Science Connect. Life Science Connect Mission: To connect the people, ideas, and organizations needed to advance the development of pharmaceuticals, biologics, diagnostics, and medical devices that improve the human condition so that they can be brought to market in a safe and cost-effective manner.
Verified activity
Signals from Life Science Leader
5 published signals
Presence & Recognition
Life Science Leader welcomed speakers including Chief R&D Data Science Officer, CEO of Johnson & Johnson, and executives from Eli Lilly, Biogen, and others to the CNS Summit 2026 I November 1–4 in Encore Boston Harbor.
Reported by Life Science Leader
Presence & Recognition
Life Science Leader featured Silvia Cerolini, Founder & CEO of Eyes on the Future and leader of the Global RDH12 Alliance at a discussion on new funding pathways for preclinical and early-stage drug development on September 15, 2026.
Reported by Life Science Leader
Legal & Regulatory
Life Science Leader reports that a recent Nasdaq rule change introduces a new continued-listing standard tied to market value of listed securities (MVLS) for micro-cap and development-stage life sciences companies.
Reported by Life Science Leader
Presence & Recognition
Life Science Leader is hosting an event on September 15 featuring experts discussing new sources of capital, emerging investment models, and creative financing approaches for biotech companies.
Reported by Life Science Leader
Presence & Recognition
Life Science Leader is hosting a live on-demand panel featuring Dr. Jeremy M. Levin of Ovid Therapeutics, Annetta Beauregard of BIO, and Paul Hastings of Nkarta, Inc. to discuss FDA changes and engagement strategies.
Reported by Life Science Leader